These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9835215)

  • 21. Prolonged intestinal afferent nerve discharge in response to cholecystokinin-58 compared to cholecystokinin-8 in rats.
    Kreis ME; Zittel TT; Raybould HE; Reeve JR; Grundy D
    Neurosci Lett; 1997 Jul; 230(2):89-92. PubMed ID: 9259471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
    Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
    Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats.
    Li Y; Hao Y; Zhu J; Owyang C
    Gastroenterology; 2000 Jun; 118(6):1197-207. PubMed ID: 10833495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin and prostaglandins inhibit responses of vagal afferent activity to systemic administration of nicotine in anesthetized rats.
    Kurosawa M; Taniguchi T; Yoneda M
    Neurosci Lett; 2004 May; 362(3):213-5. PubMed ID: 15158017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of CCK pretreatment on the CCK sensitivity of rat polymodal gastric vagal afferent in vitro.
    Wei JY; Wang YH
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E695-706. PubMed ID: 10950839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor subtype specific activation of the rat gastric vagal afferent fibers to serotonin.
    Uneyama H; Niijima A; Tanaka T; Torii K
    Life Sci; 2002 Dec; 72(4-5):415-23. PubMed ID: 12467882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High fat diet attenuates glucose-dependent facilitation of 5-HT3 -mediated responses in rat gastric vagal afferents.
    Troy AE; Simmonds SS; Stocker SD; Browning KN
    J Physiol; 2016 Jan; 594(1):99-114. PubMed ID: 26456775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin selectively affects presympathetic vasomotor neurons and sympathetic vasomotor outflow.
    Sartor DM; Verberne AJ
    Am J Physiol Regul Integr Comp Physiol; 2002 Apr; 282(4):R1174-84. PubMed ID: 11893623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of 5-HT3 receptors in activation of abdominal sympathetic C fibre afferents during ischaemia in cats.
    Fu LW; Longhurst JC
    J Physiol; 1998 Jun; 509 ( Pt 3)(Pt 3):729-40. PubMed ID: 9596795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mediation by 5-HT3 receptors of an excitatory effect of 5-HT on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.
    Wang Y; Ramage AG; Jordan D
    Br J Pharmacol; 1996 Aug; 118(7):1697-704. PubMed ID: 8842434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased food intake and CCK receptor antagonists: beyond abdominal vagal afferents.
    Ritter RC
    Am J Physiol Regul Integr Comp Physiol; 2004 Jun; 286(6):R991-3. PubMed ID: 15142854
    [No Abstract]   [Full Text] [Related]  

  • 32. The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats.
    Eberle-Wang K; Simansky KJ
    Pharmacol Biochem Behav; 1992 Nov; 43(3):943-7. PubMed ID: 1448490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans.
    Burdyga G; Lal S; Spiller D; Jiang W; Thompson D; Attwood S; Saeed S; Grundy D; Varro A; Dimaline R; Dockray GJ
    Gastroenterology; 2003 Jan; 124(1):129-39. PubMed ID: 12512037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of gastric mechanoreceptor discharge by cholecystokinin in the rat.
    Grundy D; Bagaev V; Hillsley K
    Am J Physiol; 1995 Feb; 268(2 Pt 1):G355-60. PubMed ID: 7864132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin.
    Peters JH; Karpiel AB; Ritter RC; Simasko SM
    Endocrinology; 2004 Aug; 145(8):3652-7. PubMed ID: 15105382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway.
    Glatzle J; Darcel N; Rechs AJ; Kalogeris TJ; Tso P; Raybould HE
    Am J Physiol Regul Integr Comp Physiol; 2004 Aug; 287(2):R354-9. PubMed ID: 15117731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
    Ito H; Akuzawa S; Tsutsumi R; Kiso T; Kamato T; Nishida A; Yamano M; Miyata K
    Neuropharmacology; 1995 Jun; 34(6):631-7. PubMed ID: 7566499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capsaicin-sensitive vagal fibres and 5-HT3-, gastrin releasing peptide- and cholecystokinin A-receptors are involved in distension-induced inhibition of gastric emptying in the rat.
    Bozkurt A; Oktar BK; Kurtel H; Alican I; Coşkun T; Yeğen BC
    Regul Pept; 1999 Sep; 83(2-3):81-6. PubMed ID: 10511461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between gastric motility and gastric vagal afferent responses to CCK and GRP in rats differ.
    Schwartz GJ; Moran TH; White WO; Ladenheim EE
    Am J Physiol; 1997 Jun; 272(6 Pt 2):R1726-33. PubMed ID: 9227583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visceral afferents and metabolic function.
    Niijima A
    Diabetologia; 1981 Mar; 20 Suppl():325-30. PubMed ID: 7014328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.